In this study, we report, for the first time, that claudin-9 (CLDN9) is expressed in mammary tissues and that the increased expression in breast cancer, particularly when co-expressed with its anchorage protein ZO1 and ZO3, forms a significant predictor for the survival of patients. This evidence concerns the gene CLDN9 and breast carcinoma.